EMPE Diagnostics is a leading brand that specializes in providing innovative diagnostic test kits, particularly for Tuberculosis (TB). In high TB burden countries, where access to accurate diagnostic tests is limited, EMPE Diagnostics offers a solution. Their diagnostic test kits enable clinicians to rapidly initiate effective therapy for TB patients, preventing the spread of drug-resistant TB.

EMPE's diagnostic platform is designed to be inexpensive, user-friendly, and customizable for resource-limited clinical laboratories. The multiplex molecular test included in their kits detects the presence of Mycobacterium tuberculosis and provides a genotypic resistance profile. Within just 3 hours, clinicians can receive confirmatory results in a simple 'YES' or 'NO' format.

One of EMPE's notable products is the mfloDx™ MDR-TB Kit, which is inexpensive, easy to interpret, and does not require an advanced instrument. By accurately identifying drug resistance in Tuberculosis, EMPE Diagnostics helps doctors select appropriate drugs for effective antibiotic treatment and limit the transmission of drug resistance. With a commitment to improving TB services globally, EMPE Diagnostics is at the forefront of combating the impact of the COVID-19 pandemic on TB diagnosis and treatment.

Their goal is to restore access to essential TB services, ensuring levels of case detection and treatment recover to pre-pandemic levels. Joining forces with Ukraine for TB care during a time of war and commencing a multi-country evaluation of mfloDx™ MDR-TB in Indonesia, EMPE Diagnostics demonstrates its dedication to addressing TB challenges worldwide. Choose EMPE Diagnostics for reliable, user-friendly, and rapid diagnostic solutions to combat Tuberculosis and enhance patient care